hydroxypropyl-gamma-cyclodextrin has been researched along with gliclazide in 1 studies
| Studies (hydroxypropyl-gamma-cyclodextrin) | Trials (hydroxypropyl-gamma-cyclodextrin) | Recent Studies (post-2010) (hydroxypropyl-gamma-cyclodextrin) | Studies (gliclazide) | Trials (gliclazide) | Recent Studies (post-2010) (gliclazide) |
|---|---|---|---|---|---|
| 86 | 0 | 34 | 304 | 2 | 214 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Azuma, T; Inoue, J; Ishida, T; Kawauchi, S; Kondo, Y; Maeda, H; Miki, I; Mizuno, S; Nakayama, H; Nishiumi, S; Takeuchi, A; Tanahashi, T; Tode, C; Yagi, S; Yoshida, M | 1 |
1 other study(ies) available for hydroxypropyl-gamma-cyclodextrin and gliclazide
| Article | Year |
|---|---|
Effect of 18β-glycyrrhetinic acid and hydroxypropyl γcyclodextrin complex on indomethacin-induced small intestinal injury in mice.
Topics: Animals; Biological Availability; gamma-Cyclodextrins; Gene Expression Regulation; Glycyrrhetinic Acid; Indomethacin; Interleukin-1beta; Interleukin-6; Intestine, Small; Male; Mice; Mice, Inbred C57BL; RNA, Messenger; Solubility; Tumor Necrosis Factor-alpha | 2013 |